Regulation of dopamine receptors and motor behavior following pulsatile and continuous dopaminergic replacement strategies in the MPTP primate model.
Blanchet
P J
PJ
Neurosciences Research Unit, Hôpital Saint-Luc du CHUM, Montreal, Québec H2X 3J4, Canada.
Calon
F
F
Morissette
M
M
Goulet
M
M
Grondin
R
R
Lévesque
D
D
Bédard
P J
PJ
Di Paolo
T
T
D000634:Aminoquinolines / Q000494:pharmacology; D000818:Animals; D001522:Behavior, Animal / Q000187:drug effects; D001552:Benzazepines / Q000494:pharmacology; D000077465:Cabergoline; D004195:Disease Models, Animal; D018491:Dopamine Agonists / Q000494:pharmacology*; D004873:Ergolines / Q000494:pharmacology; D005260:Female; D015870:Gene Expression / Q000187:drug effects; D007093:Imidazoles / Q000494:pharmacology; D015918:Infusion Pumps, Implantable; D008252:Macaca fascicularis; D009043:Motor Activity / Q000187:drug effects*; D020734:Parkinsonian Disorders / Q000188:drug therapy* / Q000378:metabolism*; D020551:Pulse Therapy, Drug; D012333:RNA, Messenger / Q000032:analysis; D011954:Receptors, Dopamine / Q000235:genetics / Q000378:metabolism*; D017447:Receptors, Dopamine D1 / Q000235:genetics / Q000378:metabolism; D017448:Receptors, Dopamine D2 / Q000235:genetics / Q000378:metabolism; D050637:Receptors, Dopamine D3
D000634:Aminoquinolines; D001552:Benzazepines; D018491:Dopamine Agonists; D004873:Ergolines; D007093:Imidazoles; D012333:RNA, Messenger; D011954:Receptors, Dopamine; D017447:Receptors, Dopamine D1; D017448:Receptors, Dopamine D2; D050637:Receptors, Dopamine D3; C083374:5-propylamino-5,6-dihydro-4H-imidazo(4,5,1-ij)quinolin-2(1H)-one; C071262:SK&F 82958; D000077465:Cabergoline